Cleared Traditional

K192625 - PG Pro Microcatheter

K192625 is the FDA 510(k) clearance for PG Pro Microcatheter by MicroVention, Inc. A TERUMO Group Company. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Traditional 510(k) pathway after a 59-day FDA review.

K192625 · MicroVention, Inc. A TERUMO Group Company · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2019
Decision
59d
Days
Class 2
Risk

K192625 is an FDA 510(k) clearance for the PG Pro Microcatheter. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by MicroVention, Inc. A TERUMO Group Company (Aliso Viejo, US). The FDA issued a Cleared decision on November 21, 2019 after a review of 59 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all MicroVention, Inc. A TERUMO Group Company devices

Submission Details

510(k) Number K192625 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 23, 2019
Decision Date November 21, 2019
Days to Decision 59 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
66d faster than avg
Panel avg: 125d · This submission: 59d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 573
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K192625.
Lumax Guiding Catheter
K191163 · Cook Incorporated · Dec 2019
ASAHI CROSSWALK Peripheral Support Catheter
K192782 · Asahi Intecc Co., Ltd. · Nov 2019
AXS Infinity LS Plus Long Sheath
K193034 · Stryker Neurovascular · Nov 2019
Selectra Catheters, Selectra Accessory Kit, Selectra Slitter Tool
K192996 · Biotronik, Inc. · Nov 2019
CERENOVUS Large Bore Catheter
K191237 · Codman & Shurtleff, Inc. · Nov 2019
087 Balloon Guide Catheter System
K192525 · Q'Apel Medical, LLC · Oct 2019